This is a routine investor conference participation announcement with no material information. Monitor upcoming conferences for potential pipeline updates or partnership discussions, but no immediate trading catalyst is present.
Price Chart
Executive Summary
Entera Bio announced that CEO Miranda Toledano will present at three upcoming investor conferences (Cantor, Guggenheim, Evercore) between September and December 2026. This is a routine investor relations activity with no new clinical, regulatory, or financial data disclosed. The press release reiterates the company's pipeline but provides no material updates on trial results, regulatory filings, or financial performance.
Key Facts
- CEO Miranda Toledano to participate in Cantor Global Healthcare Conference (Sept 10), Guggenheim Healthcare Innovation Conference (Nov 9), and Evercore Healthcare Conference (Nov 30–Dec 2)
- No new clinical data, regulatory updates, or financial results were disclosed
- Pipeline includes EB613 (oral PTH for osteoporosis), EB612 (hypoparathyroidism), oral oxyntomodulin (obesity), and oral GLP-2 (short bowel syndrome)
Financial Impact
No financial data disclosed
Risk Factors
- No new clinical or regulatory data to drive near-term stock movement
- Conference participation alone does not indicate imminent milestones
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3352124 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | DEF 14A | $2.77 | awaiting T+60 | — | $2.92 (+5.42%) |
Oct 6, 2026 20d ago | 8-K | $2.53 | awaiting T+60 | — | $2.92 (+15.42%) |
Aug 27, 2026 8w ago | Press Release | $3.08 | awaiting T+60 | — | $2.92 (−5.19%) |
Aug 18, 2026 9w ago | 8-K | $2.89 | awaiting T+60 | — | $2.92 (+1.04%) |
Aug 7, 2026 11w ago | Press Release | $3.04 | awaiting T+60 | — | $2.92 (−3.95%) |
Jul 29, 2026 12w ago | Press Release | $3.00 $3.02 | ▲ +0.67% | ▼ −4.06% | $2.92 (−2.67%) |
Jun 16, 2026 18w ago | Press Release | $1.18 $2.79 | ▲ +136.44% | ▲ +135.44% | $2.92 (+147.46%) |
May 28, 2026 21w ago | Press Release | $1.22 $3.23 | ▲ +164.75% | ▲ +163.02% | $2.92 (+139.34%) |
May 18, 2026 23w ago | EFFECT | $1.23 $2.80 | ▲ +127.64% | ▲ +122.79% | $2.92 (+137.40%) |
May 8, 2026 24w ago | S-3 | $1.17 $2.81 | ▲ +140.17% | ▲ +135.78% | $2.92 (+149.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers